Page last updated: 2024-12-11

n-(2-naphthalenesulfonyl)aspartyl-(2-phenethyl)amide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

N-(2-naphthalenesulfonyl)aspartyl-(2-phenethyl)amide: structure given in first source; cholecystokinin receptor antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9867157
CHEMBL ID288641
MeSH IDM0215435

Synonyms (13)

Synonym
PDSP2_000277
PDSP1_000278
2-nap
CHEMBL288641 ,
141577-40-4
n-(2-naphthalenesulfonyl)aspartyl-(2-phenethyl)amide
butanoic acid, 3-((2-naphthalenylsulfonyl)amino)-4-oxo-4-((2-phenylethyl)amino)-, (s)-
VMYREBYTVVSDDK-FQEVSTJZSA-N ,
DTXSID30931131
4-hydroxy-3-[(naphthalene-2-sulfonyl)amino]-4-[(2-phenylethyl)imino]butanoic acid
(3s)-3-(naphthalen-2-ylsulfonylamino)-4-oxo-4-(2-phenylethylamino)butanoic acid
bdbm50469591
PD180616
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (15.00)18.2507
2000's7 (35.00)29.6817
2010's2 (10.00)24.3611
2020's8 (40.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.76%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (95.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]